SEBI's most recent directive requires Registrar and Transfer Agents (RTAs), asset management companies (AMCs), and depository participants to maintain regular customer communications. Post author By admin Post date December 29, 2023 SEBI Extends Deadline for Demat and Mutual Fund Nominations to June 30, 2024 In an important decision by The Securities and Exchange Board of India (SEBI), the… 29 December 2023, • 2 mins read Tags AMCs, Demat Accounts, Investors, Mutual Fund, Nomination, Non-Compliance, PAN, SEBI, TRADING
The market immediately responded to these transactions, evident in Orchid Pharma's stock gaining 2% upon opening on the NSE the day after Dhanuka Laboratories' stake sale. Post author By admin Post date November 29, 2023 Dhanuka Labs Sells 2.56% Promoter Stake in Orchid Pharma Orchid Pharma, a Chennai-based pharmaceutical company, witnessed a notable development in its ownership structure… 29 November 2023, • 2 mins read Tags Dhanuka Laboratories, investor, MK Dhanuka, Mutual Fund, NSE, Orchid Pharma, share, share market, Stakeholders, UTI
SEBI is designed to safeguard investors' assets and ensure their smooth transition to legal heirs if circumstances demand. Post author By admin Post date September 28, 2023 SEBI Announces New Deadline for Mutual Fund Nomination Compliance Extended Deadline The Securities and Exchange Board of India (SEBI) has provided a breather… 28 September 2023, • 2 mins read Tags AMCs, investments, investor, Mutual Fund, RTAs, SEBI
August 2023 marked a significant milestone for the Indian Mutual Fund Industry, particularly in the equity mutual funds sector. Post author By admin Post date September 11, 2023 August 2023 Sees Surge in Equity Mutual Fund Inflows: A Deep Dive into the Data August 2023 marked a significant milestone for the Indian Mutual Fund Industry, particularly in… 11 September 2023, • 2 mins read Tags AMFI, AUM, ETFs, Mutual Fund, NFOs, SIP